Position in NVS
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$1,292,156
+$44,647 QoQ
Shares Held
8,245
+1.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#556
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Jacobi Capital Management LLC holds $62,099,576 across 14 Drug Manufacturers - General names. NVS ranks #10 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
14,180 | $17,007,918 | |
| 2 | MRK |
Merck & Co., Inc.
|
71,539 | $9,192,761 | |
| 3 | JNJ |
Johnson & Johnson
|
33,028 | $8,388,121 | |
| 4 | ABBV |
AbbVie Inc.
|
32,674 | $8,222,085 | |
| 5 | AMGN |
Amgen Inc
|
12,553 | $4,545,692 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
64,849 | $3,736,599 | |
| 7 | PFE |
Pfizer Inc
|
133,653 | $3,218,364 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
23,324 | $2,946,754 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,292,156 | 8,245 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $1,247,509 | 8,167 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,083,520 | 7,859 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,010,915 | 7,883 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $906,727 | 7,493 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $790,281 | 7,089 | Shares | Sole | 2025-05-27 | |
| 2024-12-31 | $659,664 | 6,779 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $797,663 | 6,935 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $691,138 | 6,492 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $618,201 | 6,391 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $699,318 | 6,926 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $694,787 | 6,821 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $688,307 | 6,821 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $625,048 | 6,794 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $686,931 | 7,572 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $565,742 | 7,443 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $596,781 | 7,060 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $476,394 | 5,429 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $443,472 | 5,070 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $401,049 | 4,904 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $425,817 | 4,667 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $396,370 | 4,637 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $446,181 | 4,725 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $390,798 | 4,494 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $383,160 | 4,387 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $378,445 | 4,590 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||